We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+11.3%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$52.3B
AUM Growth
+$4.34B
Cap. Flow
-$146M
Cap. Flow %
-0.28%
Top 10 Hldgs %
26.12%
Holding
2,277
New
427
Increased
521
Reduced
1,052
Closed
79

Top Buys

Rank Stock Value
1
IS
ironSource Ltd.
IS
+$136M
2
TSLA icon
Tesla
TSLA
+$119M
3
VZ icon
Verizon
VZ
+$109M
4
HD icon
Home Depot
HD
+$101M
5
PFE icon
Pfizer
PFE
+$88M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$247M
2
INTC icon
Intel
INTC
+$216M
3
F icon
Ford
F
+$145M
4
GM icon
General Motors
GM
+$143M
5
MU icon
Micron Technology
MU
+$125M

Sector Composition

Rank Sector Weight
1 Technology 25.15%
2 Healthcare 14.97%
3 Financials 14.22%
4 Consumer Discretionary 11.15%
5 Communication Services 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
OTRK
2101
DELISTED
Ontrak
OTRK
$79K ﹤0.01%
+139
New +$97.5K
GTHX
2102
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$79K ﹤0.01%
+7,740
New +$98.6K
ANGI icon
2103
Angi Inc
ANGI
$240M
$76K ﹤0.01%
+820
New +$88.7K
HIMS icon
2104
Hims & Hers Health
HIMS
$7B
$75K ﹤0.01%
+11,490
New +$83.1K
KLRS
2105
Kalaris Therapeutics
KLRS
$85.2M
$74K ﹤0.01%
+250
New +$116K
DTIL icon
2106
Precision BioSciences
DTIL
$187M
$73K ﹤0.01%
+328
New +$91.6K
MDXG icon
2107
MiMedx Group
MDXG
$635M
$73K ﹤0.01%
+12,070
New +$83.8K
SMP icon
2108
Standard Motor Products
SMP
$867M
$73K ﹤0.01%
1,395
-15,140
-92% -$759K
LU icon
2109
Lufax Holding
LU
$1.27B
$72K ﹤0.01%
3,188
BANC icon
2110
Banc of California
BANC
$3.21B
$71K ﹤0.01%
3,621
-62,200
-94% -$1.26M
CIFR icon
2111
Cipher Digital
CIFR
$8.86B
$70K ﹤0.01%
+15,170
New +$110K
YMAB
2112
DELISTED
Y-mAbs Therapeutics
YMAB
$70K ﹤0.01%
4,340
-1,703
-28% -$36.4K
KC
2113
Kingsoft Cloud Holdings
KC
$2.97B
$69K ﹤0.01%
4,400
MERC icon
2114
Mercer International
MERC
$44.7M
$69K ﹤0.01%
5,770
-730
-11% -$8.1K
XPEL icon
2115
XPEL
XPEL
$1.18B
$68K ﹤0.01%
+990
New +$71.3K
HGEN
2116
DELISTED
HUMANIGEN, INC.
HGEN
$66K ﹤0.01%
+17,690
New +$103K
FMTX
2117
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$65K ﹤0.01%
+4,580
New +$79.2K
VNET
2118
VNET Group
VNET
$2.04B
$64K ﹤0.01%
7,050
ALLK
2119
DELISTED
Allakos
ALLK
$63K ﹤0.01%
6,480
-17,008
-72% -$1.39M
VERV
2120
DELISTED
Verve Therapeutics
VERV
$63K ﹤0.01%
+1,870
New +$78.6K
TSP
2121
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
$63K ﹤0.01%
+1,770
New +$65.9K
PLL
2122
DELISTED
Piedmont Lithium
PLL
$62K ﹤0.01%
+1,190
New +$69.6K
FFAI
2123
Faraday Future Intelligent Electric
FFAI
$13.1M
0
POSH
2124
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
$60K ﹤0.01%
+3,530
New +$74.7K
API
2125
Agora
API
$337M
$59K ﹤0.01%
3,650

Similar funds

Ensign Peak Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Ensign Peak Advisors held 2,277 positions worth $52.3B, up 9% from $48B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Ensign Peak Advisors's Q4 2021 filing shows 427 new, 521 increased, 1,052 reduced and 79 closed positions. Its largest new stake was ironSource Ltd.: 13,801,563 shares worth $107M. The largest sale was AT&T, an estimated $247M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q4 2021 buy was ironSource Ltd.: 13,801,563 shares worth $107M.
  • Ensign Peak Advisors added most to Tesla in Q4 2021, an estimated $119M increase.
  • Ensign Peak Advisors's biggest Q4 2021 reduction was AT&T, cutting an estimated $247M.
  • Ensign Peak Advisors fully exited Acceleron Pharma in Q4 2021, selling an estimated $21.5M.
  • Ensign Peak Advisors's ten largest holdings make up 26% of its $52.3B portfolio in Q4 2021.
  • Ensign Peak Advisors opened 427 new positions and closed 79 in Q4 2021.
  • Ensign Peak Advisors's portfolio value rose 9% quarter-over-quarter to $52.3B.

Based on Ensign Peak Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.